(Q48576437)

12 February 2018

title

Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia. (English)

1 reference

12 February 2018

1 reference

Umemura K

1

1 reference

12 February 2018

Shimakura A

series ordinal

2

1 reference

12 February 2018

Nakashima M

series ordinal

3

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 October 1997

1 reference

12 February 2018

published in

Brain Research

1 reference

12 February 2018

volume

773

1 reference

12 February 2018

issue

1-2

1 reference

12 February 2018

page(s)

61-65

1 reference

12 February 2018

Attenuation by chlormethiazole administration of the rise in extracellular amino acids following focal ischaemia in the cerebral cortex of the rat.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

Neuroprotective effect of the AMPA receptor antagonist LY-293558 in focal cerebral ischemia in the cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

Glutamate neurotoxicity and diseases of the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

Intra-ischemic extracellular release of dopamine and glutamate is associated with striatal vulnerability to ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

Extracellular Adenosine, Inosine, Hypoxanthine, and Xanthine in Relation to Tissue Nucleotides and Purines in Rat Striatum During Transient Ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

Dynamics of extracellular metabolites in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral microdialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

The pyrimidine-derivative, BW1003C87, protects CA1 and striatal neurons following transient severe forebrain ischaemia in rats. A microdialysis and histological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

Novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonists: synthesis and structure-activity relationships of 6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-pyrido[2,3-b]pyrazinedione and related compounds.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

Cerebroprotective effect of BW619C89 after focal or global cerebral ischaemia in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

Inhibitory effect of MS-153 on elevated brain glutamate level induced by rat middle cerebral artery occlusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

Extracellular glutamate during focal cerebral ischaemia in rats: time course and calcium dependency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

Neuroprotective effect of YM90K, a novel AMPA/kainate receptor antagonist, in focal cerebral ischemia in cats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900894-9

10.1016/S0006-8993(97)00894-9

7 January 2021

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018